The CCIC is committed to the advancement of basic and clinical research on the therapeutic applications of cannabinoids. This section contains summaries and information on research that is available to the general public as well as more up-to-date research releases for members only. In addition, information on clinical trials, research resources and funding opportunities are provided for the public to stay informed.
Quebec Cannabis Registry’s website: www.registrecannabisquebec.com
Montreal, May 11th 2015 — The Research Institute of the McGill University Health Centre (RI-MUHC) and the Canadian Consortium for the Investigation of Cannabinoids (CCIC) have launched a registry for users of medical cannabis in Quebec that will allow physicians to better manage its use and monitor patient safety.
This innovative project represents the world’s first research database on the use of cannabis for medical purposes and places the province at the forefront of research in the field of medical cannabis. The registry was launched in response to a call by the Collège des médecins du Québec (CMQ) for guidelines on the use of medical cannabis in accordance with new government regulations. As of April 1, 2014, cannabis can only be prescribed “within a research framework,” as it is not a medically recognized treatment.
To read the full press release click here.
Survey about cannabis in e-cigarettes or portable electronic vaporizers.
A colleague from the Université de Genève is conducting an exploratory "Questionnaire for those who use cannabis in electronic cigarettes or portable electronic vaporizers".
Access the Survey at: http://www.stop-tabac.ch/fr_hon/ECIG_CAN/index_en.html